RNA Therapy Market Research Report by Technology, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

RNA Therapy Market Research Report by Technology, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • September 2020 •
  • 198 pages •
  • Report ID: 5911406 •
  • Format: PDF
RNA Therapy Market Research Report by Technology (Enabled Technologies and Enabling Technologies), by Application (Cancer, Cardiovascular, Genetic Disorders, Infectious Diseases, and Kidney Diseases), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global RNA Therapy Market is expected to grow from USD 862.49 Million in 2019 to USD 2,401.50 Million by the end of 2025.
2. The Global RNA Therapy Market is expected to grow from EUR 770.10 Million in 2019 to EUR 2,105.68 Million by the end of 2025.
3. The Global RNA Therapy Market is expected to grow from GBP 675.89 Million in 2019 to GBP 1,871.95 Million by the end of 2025.
4. The Global RNA Therapy Market is expected to grow from JPY 94,018.26 Million in 2019 to JPY 256,300.90 Million by the end of 2025.
5. The Global RNA Therapy Market is expected to grow from AUD 1,240.86 Million in 2019 to AUD 3,487.29 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the RNA Therapy to forecast the revenues and analyze the trends in each of the following sub-markets:

"The Enabling Technologies is projected to witness the highest growth during the forecast period"

Based on Technology, the RNA Therapy Market studied across Enabled Technologies and Enabling Technologies. The Enabled Technologies further studied across Inhibition, Labeling, Linear amplification, Microarrays, Purification, and qRT-PCR. The Enabling Technologies further studied across RNA Antisense Technologies and RNA Interference Technologies. The Enabling Technologies commanded the largest size in the RNA Therapy Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.

"The Retinal Diseases is projected to witness the highest growth during the forecast period"

Based on Application, the RNA Therapy Market studied across Cancer, Cardiovascular, Genetic Disorders, Infectious Diseases, Kidney Diseases, Metabolic Disorders, Oncology, and Retinal Diseases. The Infectious Diseases commanded the largest size in the RNA Therapy Market in 2019. On the other hand, the Retinal Diseases is expected to grow at the fastest CAGR during the forecast period.

"The Diagnostics is projected to witness the highest growth during the forecast period"

Based on End User, the RNA Therapy Market studied across Academic Research, Diagnostics, and Drug Discovery & Development. The Drug Discovery & Development commanded the largest size in the RNA Therapy Market in 2019. On the other hand, the Diagnostics is expected to grow at the fastest CAGR during the forecast period.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the RNA Therapy Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the RNA Therapy Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global RNA Therapy Market including Alnylam Pharmaceuticals, Inc., Arbutus Biopharma Corporation, Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals, Inc., Benitec Biopharma Limited, Biogen Inc., BioNTech SE, Cartesian Therapeutics, Inc., Cenix BioScience GmbH, Dicerna Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., MiNA Therapeutics Limited, Moderna, Inc., NeuBase Therapeutics, Inc., Nordic Nanovector ASA, ProQR Therapeutics N.V., Sanofi S.A., Silence Therapeutics PLC, Sirnaomics, Inc., Spark Therapeutics, Inc., and Triplet Therapeutics, Inc..

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:
The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the RNA Therapy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:
The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global RNA Therapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global RNA Therapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global RNA Therapy Market?
4. What is the competitive strategic window for opportunities in the Global RNA Therapy Market?
5. What are the technology trends and regulatory frameworks in the Global RNA Therapy Market?
6. What are the modes and strategic moves considered suitable for entering the Global RNA Therapy Market?